Deborah E. Faulkner, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 11578 Highway 27, Summerville, GA 30747 Phone: 706-857-5441 Fax: 888-857-9969 |
Mrs. Shannon Owensby, RN Registered Nurse - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 83 Highway 48, Summerville, GA 30747 Phone: 706-857-5441 |
News Archive
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Deferoxamine Mesylate for Injection, USP, in two dosage strengths. Deferoxamine Mesylate is therapeutically equivalent to the reference-listed drug Desferal®, which is marketed by the innovator Novartis.
Genmab A/S announced today that data from the pivotal trial of zalutumumab in refractory head and neck cancer patients will be presented today at the 2010 American Society of Clinical Oncology Annual Meeting, which will be held June 1-8 in Chicago, Illinois. This is the first controlled study to demonstrate that an EGFr-targeted antibody given as monotherapy induces a clinically meaningful improvement in progression free survival in patients with refractory head and neck cancer who have failed platinum-based chemotherapy.
A new study has shown that although we have a good supply of calorie-rich foods, most people are lacking several micronutrients in their diet.
Today, the Golden Jubilee National Hospital held its Annual Review, demonstrating that they have continued to lead the way in safe, effective and person centred care for the NHS in Scotland.
We all know it from biology lessons at school: Antibodies help us to ward off disease and are essential components of our immune system. What many people do not know is that physicians and scientists use animal antibodies to identify diseased or mutated cells.
› Verified 9 days ago